Affinage

POLG2

DNA polymerase subunit gamma-2 · UniProt Q9UHN1

Length
485 aa
Mass
54.9 kDa
Annotated
2026-06-10
20 papers in source corpus 10 papers cited in narrative 10 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 5/5 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

POLG2 encodes the p55 accessory subunit of mitochondrial DNA polymerase gamma (pol γ), required for processive mitochondrial DNA synthesis and viable mitochondrial biogenesis (PMID:16685652, PMID:23197651). p55 directly binds the p140 catalytic subunit, an interaction that stimulates the catalytic subunit and enhances the DNA-binding strength of the holoenzyme to enable processive synthesis (PMID:16685652, PMID:21555342). Beyond its role as a holoenzyme partner, p55 binds DNA autonomously in distinct dimeric and hexameric modes and localizes to DNA crossings and forked structures resembling the mitochondrial D-loop; disrupting these DNA-binding interfaces impairs processive synthesis without altering subunit affinities, establishing a PolG-independent DNA-binding function (PMID:37592734). Disease-associated p55 variants converge on a small set of mechanisms: loss of p140 binding and processivity stimulation (P205R, R369G), impaired protein stability (R182W), and C-terminal truncations that abolish both p140 and dsDNA binding while forming aberrant oligomers (L475DfsX2); the WT/G451E heterodimer acts as a dominant negative (PMID:21555342, PMID:22155748, PMID:30157269, PMID:26123486). Loss of p55 function causes mtDNA depletion with mitochondrial ultrastructural collapse and embryonic lethality in mice, and reduced POLG2 protein in patients is associated with multiple mtDNA deletions, mosaic cytochrome c oxidase deficiency, and adult-onset neurological disease (PMID:23197651, PMID:28078310). Zebrafish polg2 knockout recapitulates POLG-related mitochondrial disease with mtDNA depletion, respiratory deficiency, and motor impairment (PMID:38643274).

Mechanistic history

Synthesis pass · year-by-year structured walk · 9 steps
  1. 2006 High

    Established the molecular basis by which a POLG2 disease mutation causes pol γ dysfunction, showing that p55 acts through physical engagement of the catalytic subunit rather than through its own DNA binding.

    Evidence In vitro reconstitution of recombinant G451E p55 with subunit-interaction, stimulation, and DNA-binding assays

    PMID:16685652

    Open questions at the time
    • Did not resolve structural interface of the p140-p55 contact
    • Single point mutation; did not survey the variant spectrum
  2. 2011 High

    Systematically mapped how diverse POLG2 variants disrupt function, distinguishing variants that impair p140 binding and processivity from truncations that lose DNA binding and oligomerize aberrantly, and from biochemically silent variants.

    Evidence In vitro processivity, p140-binding, dsDNA-binding, and self-dimerization assays on multiple purified recombinant variants; complemented by an independent study of R369G including NEM-sensitivity testing

    PMID:21555342 PMID:22155748

    Open questions at the time
    • Mechanistic consequence of aberrant oligomer formation not defined
    • Did not test variant behavior in cellular mtDNA maintenance
  3. 2012 High

    Demonstrated that p55 is indispensable for mammalian development and mtDNA maintenance, defining the in vivo consequence of complete loss of function.

    Evidence Homozygous and heterozygous Polg2 knockout mice with mtDNA quantification, gene-product assessment, and EM ultrastructure

    PMID:23197651

    Open questions at the time
    • Embryonic lethality precludes tissue-specific adult phenotyping
    • Did not separate catalytic-support from PolG-independent DNA functions
  4. 2015 High

    Linked variant biochemistry to cellular consequences, showing dominant-negative heterodimer behavior, mislocalization away from mtDNA nucleoids, and impaired mitochondrial reserve capacity.

    Evidence Tandem affinity purification of heterodimers with in vitro pol γ activity assay; GFP-tagged variant imaging in HEK293; Seahorse bioenergetics

    PMID:26123486

    Open questions at the time
    • Overexpression context may not reflect endogenous variant dosage
    • Mechanism coupling mislocalization to nucleoid dysfunction unresolved
  5. 2016 Medium

    Extended the disease mechanism to loss-of-quantity, showing a splice variant lowers POLG2 protein and is associated with multiple mtDNA deletions and COX deficiency in patient tissue.

    Evidence Segregation analysis, Western blot of patient fibroblasts, EM, COX activity, and mtDNA deletion analysis

    PMID:28078310

    Open questions at the time
    • No in vitro reconstitution of the splice product
    • Causality inferred from segregation and protein level, not direct rescue
  6. 2018 High

    Identified protein instability as a discrete pathogenic mechanism distinct from binding or catalytic defects, since R182W retains all measured biochemical activities yet is thermally unstable and depletes mtDNA in cells.

    Evidence Differential scanning fluorimetry and thermal inactivation alongside DNA-binding, p140-association, primer-extension and exonuclease-suppression assays; patient fibroblasts and HEK293 Seahorse

    PMID:30157269

    Open questions at the time
    • In vivo turnover and degradation pathway of unstable p55 not characterized
  7. 2023 High

    Revealed a PolG-independent DNA-binding role for p55, defining dimeric and hexameric DNA-binding modes and targeting of forked/D-loop structures whose disruption impairs processivity without altering subunit affinity.

    Evidence X-ray crystallography of PolG2-DNA complexes, AFM, interface mutagenesis, and in vitro processive synthesis assays

    PMID:37592734

    Open questions at the time
    • In vivo role of D-loop targeting during mtDNA replication not directly tested
    • Functional significance of the hexameric mode in cells unresolved
  8. 2024 Medium

    Provided a tractable vertebrate disease model and a candidate intervention, with polg2 knockout zebrafish recapitulating mtDNA depletion and motor disease partially rescued pharmacologically.

    Evidence CRISPR/Cas9 zebrafish knockout with mtDNA, respiration, histology, locomotor assays and Clofilium tosylate rescue

    PMID:38643274

    Open questions at the time
    • Mechanism of Clofilium tosylate rescue undefined
    • Rescue only partial; single model organism
  9. 2025 Low

    Placed POLG2 within a regulatory axis in cancer, where Nrf2 signaling stabilizes POLG2 to support mitochondrial respiration in AML cells.

    Evidence AML cell-line assays with Nrf2/ALDH2 inhibition, POLG2 protein measurement, OXPHOS readouts, and xenograft

    PMID:40796730

    Open questions at the time
    • No direct biochemical reconstitution of Nrf2-ALDH2-POLG2 regulation
    • Mechanism of POLG2 stabilization not defined
    • Single lab, correlative pathway data

Open questions

Synthesis pass · forward-looking unresolved questions
  • How the PolG-independent DNA-binding/D-loop targeting activity functions during mtDNA replication in vivo, and how it is integrated with the holoenzyme role, remains open.
  • No in vivo separation-of-function study of DNA-binding versus catalytic-support roles
  • Regulation of p55 oligomeric state in cells unknown

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0003677 DNA binding 3 GO:0098772 molecular function regulator activity 3
Localization
GO:0005739 mitochondrion 2
Pathway
R-HSA-69306 DNA Replication 3 R-HSA-1640170 Cell Cycle 1
Partners
POLG
Complex memberships
DNA polymerase gamma (pol γ) holoenzyme

Evidence

Reading pass · 10 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2006 The POLG2-encoded p55 accessory subunit of DNA polymerase gamma (pol γ) directly interacts with the p140 catalytic subunit; the G451E disease mutation in p55 compromises this subunit interaction, resulting in incomplete stimulation of the catalytic subunit and failure to enhance the DNA-binding strength of the p140-p55 complex, despite retaining wild-type DNA-binding ability on its own. In vitro biochemical characterization of purified recombinant G451E-substituted p55 protein; subunit interaction assays; DNA-binding assays American journal of human genetics High 16685652
2011 Biochemical characterization of seven POLG2 disease variants showed that the P205R and R369G p55 variants have reduced stimulation of polymerase processivity and decreased affinity for the p140 catalytic subunit, while the L475DfsX2 (C-terminal truncation) variant cannot bind p140, cannot bind dsDNA, and forms aberrant oligomeric complexes. Variants G103S, L153V, D386E and S423Y displayed wild-type biochemical behavior. In vitro biochemical assays: stimulation of processive DNA synthesis, p140 catalytic subunit binding, dsDNA binding, and self-dimerization assays using purified recombinant proteins Human molecular genetics High 21555342
2011 The POLG2 p.R369G variant reduces affinity between the p55 accessory subunit and the p140 catalytic subunit, leading to impaired processivity of the pol γ holoenzyme. This variant does not show sensitivity to N-ethylmaleimide (NEM) inhibition, indicating a novel disease mechanism distinct from previously characterized mutations. Biochemical studies of recombinant mutant p55 protein: subunit affinity assays, processivity assays, NEM inhibition assay Mitochondrion Medium 22155748
2012 Polg2 is essential for mammalian embryogenesis; homozygous knockout (Polg2−/−) mice are embryonic lethal at day 8.0–8.5 with concomitant loss of mtDNA and mtDNA gene products, severe ultrastructural defects and loss of organized cristae in mitochondria, and increased lipid accumulation. Heterozygous Polg2+/− mice are haplosufficient and develop normally. Genetic knockout mouse model (homozygous and heterozygous); electron microscopy; mtDNA quantification; assessment of mtDNA gene products Human molecular genetics High 23197651
2015 The WT/G451E p55 heterodimer acts as a dominant negative protein, impairing pol γ function in vitro. P205R and L475DfsX2 p55 variants show irregular diffuse mitochondrial localization in HEK293 cells, failing to form distinct puncta associated with mtDNA nucleoids (unlike WT p55). These variants also form aberrant reducible multimers. Overexpression of p55 disease variants impairs mitochondrial reserve capacity in stable cell lines. Tandem affinity purification to isolate p55 heterodimers; in vitro pol γ activity assay; GFP-tagged p55 variants expressed in HEK293 cells with live fluorescence imaging; mitochondrial bioenergetics measurement (Seahorse assay); biochemical analysis of multimer formation Human molecular genetics High 26123486
2018 The homozygous R182W substitution in POLG2 p55 severely impairs protein stability (as measured by differential scanning fluorimetry and thermal inactivation assays) but does not abolish DNA binding, association with p140, stimulation of primer extension, steady-state nucleotide incorporation, or suppression of pol γ exonuclease function in vitro. In cells, R182W p55 causes reduced mtDNA copy number and impairs oxidative phosphorylation. In vitro biochemical assays (DNA binding, p140 association, primer extension, steady-state nucleotide incorporation, exonuclease suppression); differential scanning fluorimetry; thermal inactivation; cultured primary dermal fibroblasts (doubling time, mtDNA copy number); HEK293 overexpression with Seahorse bioenergetics PloS one High 30157269
2023 PolG2 directly binds DNA in two distinct modes — dimeric and hexameric — as defined by X-ray crystal structures and Atomic Force Microscopy (AFM) of PolG2-DNA complexes. Targeted disruption of PolG2 DNA-binding interfaces impairs processive DNA synthesis without diminishing pol γ subunit affinities, demonstrating a PolG-independent DNA-binding function. Oligomeric PolG2 localizes to DNA crossings and targets forked DNA structures resembling the mitochondrial D-loop, revealed by X-ray structures and AFM. X-ray crystallography of PolG2-DNA complexes; Atomic Force Microscopy (AFM); site-directed mutagenesis of DNA-binding interfaces; in vitro processive DNA synthesis assays; subunit affinity measurements Nucleic acids research High 37592734
2016 A POLG2 splice acceptor variant (c.970-1G>C) segregating with adult-onset neurological disease causes a concomitant decrease in POLG2 protein levels in patient cells, demonstrating that reduced POLG2 protein is associated with mosaic cytochrome c oxidase deficiency and multiple mtDNA deletions in patient tissues. Genetic sequencing and segregation analysis; Western blot quantification of POLG2 protein in patient fibroblasts; mitochondrial function analyses (electron microscopy, COX activity, mtDNA deletion analysis) Annals of clinical and translational neurology Medium 28078310
2024 Zebrafish homozygous polg2 knockout (frameshift/premature stop by CRISPR/Cas9) recapitulates human POLG-related disease, exhibiting mtDNA depletion, altered mitochondrial network and dynamics, reduced mitochondrial respiration, skeletal muscle fibre disorganization, and decreased larval motility. Treatment with Clofilium tosylate partially rescued mtDNA depletion in polg2 mutant animals. CRISPR/Cas9 zebrafish knockout; mtDNA copy number quantification; mitochondrial respiration assay; histological analysis; locomotor assays; pharmacological rescue with Clofilium tosylate Cell death & disease Medium 38643274
2025 Nrf2 promotes mitochondrial respiration in AML cells by activating ALDH2 expression and stabilizing POLG2 expression in mitochondria; inhibition of the Nrf2-ALDH2/POLG2 pathway reduces oxidative phosphorylation and mitochondrial biosynthesis in AML cells. Cell-based assays in AML cell lines; genetic perturbation (inhibition of Nrf2 and ALDH2); measurement of POLG2 protein levels; assessment of oxidative phosphorylation and mitochondrial respiration; in vivo xenograft model Cell death & disease Low 40796730

Source papers

Stage 0 corpus · 20 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2006 Mutant POLG2 disrupts DNA polymerase gamma subunits and causes progressive external ophthalmoplegia. American journal of human genetics 187 16685652
2012 Polg2 is essential for mammalian embryogenesis and is required for mtDNA maintenance. Human molecular genetics 64 23197651
2011 Biochemical analysis of human POLG2 variants associated with mitochondrial disease. Human molecular genetics 56 21555342
2016 Oral Helicobacter pylori vaccine-encapsulated acid-resistant HP55/PLGA nanoparticles promote immune protection. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 47 27865932
2008 Progressive external ophthalmoplegia and vision and hearing loss in a patient with mutations in POLG2 and OPA1. Archives of neurology 39 18195150
2010 Late-onset ptosis and myopathy in a patient with a heterozygous insertion in POLG2. Journal of neurology 34 20405137
2015 POLG2 disease variants: analyses reveal a dominant negative heterodimer, altered mitochondrial localization and impaired respiratory capacity. Human molecular genetics 31 26123486
2016 Whole exome sequencing identifies a homozygous POLG2 missense variant in an infant with fulminant hepatic failure and mitochondrial DNA depletion. European journal of medical genetics 23 27592148
2011 A p.R369G POLG2 mutation associated with adPEO and multiple mtDNA deletions causes decreased affinity between polymerase γ subunits. Mitochondrion 21 22155748
2016 POLG2 deficiency causes adult-onset syndromic sensory neuropathy, ataxia and parkinsonism. Annals of clinical and translational neurology 17 28078310
2018 Characterization of the human homozygous R182W POLG2 mutation in mitochondrial DNA depletion syndrome. PloS one 14 30157269
2023 Structure-specific roles for PolG2-DNA complexes in maintenance and replication of mitochondrial DNA. Nucleic acids research 11 37592734
2019 Whole exome sequencing identifies a homozygous POLG2 missense variant in an adult patient presenting with optic atrophy, movement disorders, premature ovarian failure and mitochondrial DNA depletion. European journal of medical genetics 9 31778857
2024 Zebrafish polg2 knock-out recapitulates human POLG-disorders; implications for drug treatment. Cell death & disease 7 38643274
2011 A polymorphism of the POLG2 gene is genetically associated with the invasiveness of urinary bladder cancer in Japanese males. Journal of human genetics 7 21734712
2023 POLG2-Linked Mitochondrial Disease: Functional Insights from New Mutation Carriers and Review of the Literature. Cerebellum (London, England) 6 37085601
2020 Camptocormia as a Novel Phenotype in a Heterozygous POLG2 Mutation. Diagnostics (Basel, Switzerland) 5 31991853
2018 An N-Ethyl-N-Nitrosourea (ENU)-Induced Tyr265Stop Mutation of the DNA Polymerase Accessory Subunit Gamma 2 (Polg2) Is Associated With Renal Calcification in Mice. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 4 30395686
2025 The ALDH2/PolG2 axis enhances mitochondrial biogenesis via transcriptional regulation of Nrf2 and promotes chemotherapy resistance in acute myeloid leukaemia. Cell death & disease 2 40796730
2025 A Rare Molecular Diagnosis in a Patient With Hepatocerebral Syndrome Contributes to the Expansion of the Phenotypic Spectrum of POLG2 -Related Mitochondrial Disorder. American journal of medical genetics. Part A 0 40631390

Missed literature

Know a paper Affinage missed for POLG2? Flag it for the maintainers and the community.

No submissions yet.